The federal suit filed in Massachusetts accuses drug makers Sanofi, Novo Nordisk and Eli Lilly of raising the list prices of their products “in perfect lock step” for years.
The accusations center on the shadowy rebate system between drug makers and pharmacy benefit managers, which this news outlet has been investigating.
Read more about the lawsuit: Insulin makers accused of price-fixing scheme
More from our investigation:
In Other News
1
Ohio leads nation in tornadoes to start 2024
2
Winter Guard top finishers included Dayton-area teams, groups from...
3
Area state rep introduces bill for third time to protect domestic...
4
Ohio ranks 2nd in ‘Do Not Call’ complaints; here’s how you can make a...
5
Area gas prices increase as pumps continue switch to summer gasoline
About the Author